Best L, Davies S, Brown P D
Department of Medicine, University of Manchester, UK.
Diabetologia. 2004 Nov;47(11):1990-7. doi: 10.1007/s00125-004-1559-4. Epub 2004 Nov 24.
AIMS/HYPOTHESIS: Hypoglycaemic sulphonylureas are thought to stimulate insulin release by binding to a sulphonylurea receptor, closing K(ATP) channels and inducing electrical activity. However, the fact that these drugs stimulate insulin release at high glucose concentrations where K(ATP) channels are closed suggests additional ionic actions. The aim of this study was to test the hypothesis that sulphonylureas influence the current of the glucose- and volume-regulated anion channel.
Electrical and ion-channel activity were recorded in isolated rat beta cells using the patch-clamp technique. (86)Rb(+) efflux was measured using intact islets. Beta cell volume was measured using a video-imaging technique.
In the absence of glucose, tolbutamide (100 micromol/l) transiently depolarised the cells. In the presence of glucose (5 mmol/l), tolbutamide evoked a sustained period of electrical activity, whilst at 10 mmol/l glucose, the drug evoked a pronounced 'silent' depolarisation. In the absence of glucose, tolbutamide inhibited (86)Rb(+) efflux. However, at 10 mmol/l glucose, tolbutamide induced a transient stimulation of efflux. Tolbutamide potentiated the whole-cell volume-regulated anion conductance in a glucose-dependent manner with an EC(50) of 85 micromol/l. In single channel recordings, tolbutamide increased the channel-open probability. Tolbutamide caused beta cell swelling in the presence of glucose, but not in its absence.
CONCLUSIONS/INTERPRETATION: Tolbutamide can induce beta cell electrical activity by potentiating the glucose- and volume-regulated anion channel current. This effect is probably not due to a direct effect of the drug on the channel, but could be secondary to a metabolic action in the beta cell.
目的/假设:降血糖磺脲类药物被认为是通过与磺脲类受体结合、关闭K(ATP)通道并诱导电活动来刺激胰岛素释放。然而,这些药物在高葡萄糖浓度(此时K(ATP)通道已关闭)下仍能刺激胰岛素释放,这一事实提示存在其他离子作用。本研究的目的是检验磺脲类药物影响葡萄糖和容量调节性阴离子通道电流这一假设。
采用膜片钳技术记录分离的大鼠β细胞的电活动和离子通道活性。使用完整胰岛测量(86)Rb(+)外流。采用视频成像技术测量β细胞体积。
在无葡萄糖情况下,甲苯磺丁脲(100 μmol/l)使细胞短暂去极化。在有葡萄糖(5 mmol/l)存在时,甲苯磺丁脲诱发持续的电活动期,而在葡萄糖浓度为10 mmol/l时,该药物诱发明显的“沉默”去极化。在无葡萄糖情况下,甲苯磺丁脲抑制(86)Rb(+)外流。然而,在葡萄糖浓度为10 mmol/l时,甲苯磺丁脲诱导外流短暂增加。甲苯磺丁脲以葡萄糖依赖的方式增强全细胞容量调节性阴离子电导,半数有效浓度(EC(50))为85 μmol/l。在单通道记录中,甲苯磺丁脲增加通道开放概率。甲苯磺丁脲在有葡萄糖存在时导致β细胞肿胀,但在无葡萄糖时则不然。
结论/解读:甲苯磺丁脲可通过增强葡萄糖和容量调节性阴离子通道电流来诱导β细胞电活动。这种作用可能并非药物对通道的直接作用,而是β细胞代谢作用的继发效应。